These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22961750)

  • 21. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O; Minard-Colin V; Boutroux H; Brisse HJ; Levy C; Kolb F; Bolle S; Carton M; Helfre S; Orbach D
    Acta Ophthalmol; 2021 May; 99(3):334-341. PubMed ID: 32833335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.
    Oberlin O; Rey A; Anderson J; Carli M; Raney RB; Treuner J; Stevens MC;
    J Clin Oncol; 2001 Jan; 19(1):197-204. PubMed ID: 11134213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents.
    Hays DM; Shimada H; Raney RB; Tefft M; Newton W; Crist WM; Lawrence W; Ragab A; Beltangady M; Maurer HM
    Cancer; 1988 May; 61(9):1893-903. PubMed ID: 3281745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
    Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
    Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
    Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
    J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of adjuvant and neoadjuvant therapies for adult orbital sarcomas.
    Savar A; Trent J; Al-Zubidi N; Huh W; Anderson P; Shinder R; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2010; 26(3):185-9. PubMed ID: 20489544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.
    Strege RJ; Kovács G; Meyer JE; Holland D; Claviez A; Mehdorn MH;
    Strahlenther Onkol; 2009 Dec; 185(12):789-98. PubMed ID: 20013088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
    Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
    Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
    Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
    J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
    Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC
    J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study.
    Ortega JA; Wharam M; Gehan EA; Ragab AH; Crist W; Webber B; Wiener ES; Haeberlen V; Maurer HM
    J Clin Oncol; 1991 May; 9(5):796-801. PubMed ID: 2016622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
    Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
    J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
    Raney RB; Stoner JA; Walterhouse DO; Andrassy RJ; Donaldson SS; Laurie F; Meyer WH; Qualman SJ; Crist WM;
    Pediatr Blood Cancer; 2004 Jun; 42(7):618-25. PubMed ID: 15127417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
    Olivier Pascual N; Calvo JM; Abelairas Gómez JM
    Arch Soc Esp Oftalmol; 2005 Jun; 80(6):331-8. PubMed ID: 15986273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?
    Blakely ML; Lobe TE; Anderson JR; Donaldson SS; Andrassy RJ; Parham DM; Wharam MD; Qualman SJ; Wiener ES; Grier HE; Crist WM
    J Pediatr Surg; 1999 May; 34(5):736-41; discussion 741-2. PubMed ID: 10359174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P; Angiolillo A; Krailo M; Cheung YK; Anderson B; Davenport V; Reaman G; Cairo MS
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.